Health-care companies rose as traders sought out sectors less sensitive to shifts in interest-rate and economic-growth trajectories. Pfizer said it intends to sell around 540 million ordinary shares ...
This summary covers several health-related news, including Germany's bird flu outbreak, Bristol Myers' lawsuit victory, ...
Sept 30 (Reuters) - Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from ...
On completion, Pfizer, the New York-based pharmaceuticals firm, will see its interest in Haleon fall to just over 16% from 22.6% currently. Bloomberg reported that the share sale price is likely to be ...
OPEC+ is strategically reducing oil supply and ceding market share with a long-term view so that the producing countries ...
Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine ...
Goldman Sachs, JP Morgan, Morgan Stanley and UBS are global coordinators on the trade, with Barclays, Bank of America, BNP ...
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health ...
Pfizer said it intends to sell around 540 million ordinary shares in British consumer-healthcare business Haleon, or about 5.9% of the company's issued share capital. The pharmaceutical giant said ...
Pfizer said it intends to sell around 540 million ordinary shares in British consumer-healthcare business Haleon, or about 5.9% of the company's issued share capital. The pharmaceutical giant said ...
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback